Anti-Golgin-97, clone 4K16 ZooMAb�

Application

Anti-Golgin-97, clone 4K16 ZooMAb, Cat. No. ZRB1346, is a recombinant Rabbit monoclonal antibody that specifically targets Golgin-97 and has been tested for use in Immunocytochemistry, Immunohistochemistry (Paraffin) and Western Blotting.

Immunocytochemistry Analysis: A 1:100-1,000 dilution from a representative lot detected Golgin-97 in A431, HUVEC, and HepG2 cells.Immunohistochemistry (Paraffin) Analysis: A 1:100 dilution from a representative lot detected Golgin-97 in human testis tissue sections.Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.

Disclaimer

Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.

General description

ZooMAb antibodies represent an entirely new generation of recombinant monoclonal antibodies.Each ZooMAb antibody is manufactured using our proprietary recombinant expression system, purified to homogeneity, and precisely dispensed to produce robust and highly reproducible lot-to-lot consistency. Only top-performing clones are released for use by researchers. Each antibody is validated for high specificity and affinity across multiple applications, including its most commonly used application. ZooMAb antibodies are reliably available and ready to ship when you need them.Learn more about ZooMAb here.

Immunogen

KLH-conjugated linear peptide corresponding to 20 amino acids from the C-terminal region of human Gogin-97.

Legal Information

ZooMAb is a registered trademark of Merck KGaA, Darmstadt, Germany

Physical form

Purified recombinant rabbit monoclonal antibody IgG, lyophilized in PBS with 5% Trehalose, normal appearance a coarse or translucent resin. Contains no biocide or preservatives, such as azide, or any animal by-products. Larger pack sizes provided as multiples of 25 µL.

Reconstitution

300 µg/mL after reconstitution at 25 µL per vial. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.

Specificity

Clone 4K16 is a ZooMAb rabbit recombinant monoclonal antibody that specifically detects Golgin-97. It targets an epitope within 20 amino acids from the C-terminal region.

Storage and Stability

Recommend storage of lyophilized product at 2-8°C; Before reconstitution, micro-centrifuge vials briefly to spin down material to bottom of the vial; Reconstitute each vial by adding 25 µL of filtered lab grade water or PBS; Reconstituted antibodies can be stored at 2-8°C, or -20°C for long term storage. Avoid repeated freeze-thaws.

Target description

Golgin subfamily A member 1 (UniProt: Q92805; also known as Golgin-97) is encoded by the GOLGA1 gene (Gene ID: 2800) in human. Golgin-97 is a peripheral membrane protein that is involved in vesicular trafficking at the Golgi apparatus level. It participates in endosome-to-Golgi trafficking. Golgin-97 is shown to be a binding partner for potassium channel Kir2.1 and is essential for targeting this channel to trans-Golgi network. The GRIP domain (aa 688-737) of Golgin-97 associates with the cytoplasmic domain of Kir2.1. Antibodies against Golgin-97 are found in sera of patients with Sjoegren syndrome characterized by dry mouth and dry eyes. During viral infection, Golgin-97 is reportedly transported to the sites of virus replication and assembly and becomes incorporated into the virions where it associates with the insoluble core protein fraction. This ZooMAb recombinant monoclonal antibody, generated by our propriety technology, offers significantly enhanced specificity, affinity, reproducibility, and stability over conventional monoclonals. (Ref.: Alzhanova, D., and Hruby, DE. (2006). J. Virol. 80(23); 11520-11527; Taneja, TK et al. (2018). Front Physiol. 9; 1070).